Skip to Content

GXFC3 (Combivir 150 mg / 300 mg)

Generic Name: lamivudine/zidovudine

Pill with imprint GXFC3 is White, Elliptical / Oval and has been identified as Combivir 150 mg / 300 mg. It is supplied by GlaxoSmithKline.

Combivir is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Combivir 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GXFC3

Combivir 150 mg / 300 mg GXFC3 Front
Combivir 150 mg / 300 mg GXFC3 Back
Combivir 150 mg / 300 mg GXFC3
Combivir 150 mg / 300 mg GXFC3

Combivir

Generic Name
lamivudine/zidovudine
Imprint
GXFC3
Strength
150 mg / 300 mg
Color
White
Size
17.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
GlaxoSmithKline
National Drug Code (NDC)
00173-0595
Inactive Ingredients
silicon dioxide colloidal, hypromelloses, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "GXFC3"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.